HMGCR

UniProt ID: P04035
Organism: Homo sapiens
Review Status: INITIALIZED
📝 Provide Detailed Feedback

Gene Description

HMGCR encodes 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase; EC 1.1.1.34), the rate-limiting and committed enzyme of the mevalonate pathway. It catalyzes the NADPH-dependent reduction of (3S)-3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) to (R)-mevalonate and CoA, a two-step, four-electron reaction consuming two molecules of NADPH. Mevalonate is the precursor for cholesterol, dolichol, ubiquinone and the prenyl groups (farnesyl/geranylgeranyl) used in protein prenylation, so HMGCR sits at the head of sterol and non-sterol isoprenoid biosynthesis. HMGCR is a polytopic (multi-pass) endoplasmic reticulum membrane protein of 888 residues: its N-terminal membrane-anchored region contains a sterol-sensing domain that, together with INSIG proteins and SREBP/SCAP, mediates sterol-accelerated ubiquitination and ER-associated degradation and feedback regulation of the enzyme, while the C-terminal cytosolic domain is catalytic and assembles into homodimers/homotetramers. HMGCR is the molecular target of the statin class of cholesterol-lowering drugs, which act as competitive inhibitors at the HMG-CoA/cofactor site. Bi-allelic loss-of-function HMGCR variants cause an autosomal-recessive limb-girdle muscular dystrophy (LGMDR28).

Existing Annotations Review

GO Term Evidence Action Reason
GO:0004420 hydroxymethylglutaryl-CoA reductase (NADPH) activity
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic (IBA) assignment of the defining molecular function of HMGCR: NADPH-dependent reduction of HMG-CoA to mevalonate. This is the well-established catalytic activity of the enzyme, supported by direct human enzymology and crystallography, and is the core function of the gene.
Reason: Correct and specific. HMGCR is the rate-limiting enzyme of the mevalonate pathway; the IBA is corroborated by human experimental evidence.
Supporting Evidence:
PMID:10698924
catalyzes the formation of
PMID:10698924
mevalonate, the committed step
GO:0005789 endoplasmic reticulum membrane
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic assignment placing HMGCR activity in the ER membrane, consistent with its being a polytopic ER membrane protein anchored by an N-terminal multi-pass membrane domain.
Reason: ER membrane is the primary, well-established site of HMGCR; supported by human subcellular-location data and the multi-pass membrane topology in UniProt.
Supporting Evidence:
PMID:2991281
the membrane-bound glycoprotein that regulates cholesterol synthesis
file:human/HMGCR/HMGCR-uniprot.txt
Endoplasmic reticulum membrane
GO:0016126 sterol biosynthetic process
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic assignment of HMGCR to sterol biosynthesis. As the rate-limiting step producing mevalonate, HMGCR is required for cholesterol/sterol synthesis.
Reason: Accurate pathway assignment; mevalonate is the obligate precursor of sterols. Retained as a core biological process, alongside the more specific cholesterol biosynthetic process annotation.
Supporting Evidence:
PMID:10698924
the committed step in the biosynthesis of sterols and isoprenoids
GO:0008299 isoprenoid biosynthetic process
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic assignment of HMGCR to isoprenoid biosynthesis. Mevalonate is the precursor of all non-sterol isoprenoids (dolichol, ubiquinone, prenyl groups) as well as sterols.
Reason: Correct: HMGCR is the committed step producing mevalonate for both sterol and non-sterol isoprenoid branches.
Supporting Evidence:
PMID:10698924
the committed step in the biosynthesis of sterols and isoprenoids
GO:0005778 peroxisomal membrane
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: Phylogenetic assignment of HMGCR to the peroxisomal membrane. A peroxisomal pool of pre-squalene mevalonate-pathway enzymes has been reported, but this localization is contested and secondary to the dominant ER membrane pool.
Reason: Retained because there is experimental support for a peroxisomal pool of pre-squalene isoprenoid enzymes, but peroxisomal localization of these enzymes is disputed in the literature and is not the core site of HMGCR action, which is the ER membrane. Marked non-core rather than accepted as a primary location.
Supporting Evidence:
PMID:17180682
isoprenoid/cholesterol biosynthetic pathway occur in peroxisomes
GO:0004420 hydroxymethylglutaryl-CoA reductase (NADPH) activity
IEA
GO_REF:0000120
ACCEPT
Summary: Electronic (InterPro/EC/RHEA-based) assignment of the core catalytic activity. Redundant with the experimental and IBA annotations to the same term.
Reason: Correct core molecular function, mapped from HMG-CoA reductase InterPro domains, EC 1.1.1.34 and RHEA:15989. Consistent with all experimental evidence.
Supporting Evidence:
file:human/HMGCR/HMGCR-uniprot.txt
the rate-limiting step in the synthesis of
GO:0005778 peroxisomal membrane
IEA
GO_REF:0000044
KEEP AS NON CORE
Summary: UniProt Subcellular-Location keyword mapping to peroxisomal membrane, reflecting the reported (contested) peroxisomal pool of pre-squalene isoprenoid enzymes.
Reason: Consistent with the UniProt "Peroxisome membrane" subcellular location, itself based on PMID:17180682. Kept as a non-core location; the dominant and functionally central site of HMGCR is the ER membrane.
Supporting Evidence:
file:human/HMGCR/HMGCR-uniprot.txt
Peroxisome membrane
GO:0005789 endoplasmic reticulum membrane
IEA
GO_REF:0000120
ACCEPT
Summary: Electronic assignment of the primary ER membrane location, mapped from InterPro (metazoan HMGCR) and the UniProt subcellular-location keyword.
Reason: ER membrane is the established primary location of HMGCR; the electronic mapping is correct and redundant with the experimental annotations.
Supporting Evidence:
file:human/HMGCR/HMGCR-uniprot.txt
Endoplasmic reticulum membrane
GO:0008299 isoprenoid biosynthetic process
IEA
GO_REF:0000002
ACCEPT
Summary: InterPro2GO electronic mapping to isoprenoid biosynthesis from the HMG-CoA reductase domains. Correct pathway context for the mevalonate-producing step.
Reason: Correct: HMGCR produces mevalonate, the precursor of all isoprenoids. Redundant with the IBA annotation to the same term.
Supporting Evidence:
PMID:10698924
the committed step in the biosynthesis of sterols and isoprenoids
GO:0015936 coenzyme A metabolic process
IEA
GO_REF:0000002
MARK AS OVER ANNOTATED
Summary: InterPro2GO electronic mapping to coenzyme A metabolic process, triggered by the CoA-binding/substrate-binding domains. HMGCR uses HMG-CoA as substrate and releases CoA, but it is not a component of a coenzyme A metabolic pathway.
Reason: Over-annotation from a domain-to-GO rule. CoA is released as a product of the HMGCR reaction (its acyl-CoA substrate is reduced), but HMGCR does not participate in coenzyme A biosynthesis or turnover as a metabolic process. The molecular-level CoA involvement is more precisely captured by the coenzyme A binding (GO:0120225) annotation.
Supporting Evidence:
file:human/HMGCR/HMGCR-uniprot.txt
the rate-limiting step in the synthesis of
GO:0016616 oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
IEA
GO_REF:0000002
MARK AS OVER ANNOTATED
Summary: InterPro2GO electronic mapping to a general oxidoreductase parent term. HMGCR is an oxidoreductase acting with NADPH, but this term is far less specific than the exact activity GO:0004420.
Reason: Grandparent of the precise, well-supported GO:0004420 hydroxymethylglutaryl-CoA reductase (NADPH) activity. It is not wrong but is uninformative given the specific term is annotated; treated as an over-general over-annotation rather than removed.
Supporting Evidence:
PMID:10698924
catalyzes the formation of
GO:0050661 NADP binding
IEA
GO_REF:0000002
KEEP AS NON CORE
Summary: InterPro2GO electronic mapping to NADP binding. HMGCR binds NADP(H) as its redox cofactor; a more specific NADPH binding (GO:0070402) annotation with direct structural evidence also exists.
Reason: Correct at the cofactor level but redundant with and less specific than the structure-based GO:0070402 NADPH binding IDA. Kept as non-core supporting molecular detail rather than a core function.
Supporting Evidence:
file:human/HMGCR/HMGCR-uniprot.txt
the rate-limiting step in the synthesis of
GO:0005515 protein binding
IPI
PMID:23169578
The UBIAD1 prenyltransferase links menaquinone-4 [corrected]...
MARK AS OVER ANNOTATED
Summary: IPI protein-binding annotation supported by a physical interaction between HMGCR and the prenyltransferase UBIAD1 (yeast two-hybrid plus immunoprecipitation). The identifier is correct but the GO term is uninformative.
Reason: Bare "protein binding" (GO:0005515) does not convey a specific molecular function. The underlying UBIAD1 interaction is real, but per curation guidelines this generic term is flagged as an over-annotation rather than a core function; it is not removed because the experimental interaction is genuine.
Supporting Evidence:
PMID:23169578
interacts with HMGCR and SOAT1, enzymes catalyzing cholesterol synthesis and
PMID:23169578
using yeast two-hybrid screening and immunoprecipitation
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
MARK AS OVER ANNOTATED
Summary: IPI protein-binding annotation from a proteome-scale affinity-purification/mass spectrometry interactome study (BioPlex). Generic binding term with no specific molecular-function content.
Reason: High-throughput AP-MS interaction; the "protein binding" (GO:0005515) term is uninformative about molecular function. Retained (not removed) as a genuine high-throughput interaction but flagged as over-annotated per curation guidelines.
Supporting Evidence:
PMID:33961781
Through affinity-purification mass spectrometry, we have created two proteome-scale, cell-line-specific interaction networks.
GO:0042177 negative regulation of protein catabolic process
IEA
GO_REF:0000107
MARK AS OVER ANNOTATED
Summary: Electronic transfer (Ensembl Compara) from the mouse ortholog (Q01237) of a role in negatively regulating protein catabolism. This is an indirect, downstream consequence of mevalonate-pathway output rather than a direct HMGCR function.
Reason: Not a direct molecular activity or process of HMGCR; it is an orthology-transferred regulatory effect several steps removed from the enzyme's catalytic role. Treated as an over-annotation rather than removed, since it is an electronic ortholog transfer that may reflect a real but indirect pleiotropic effect.
Supporting Evidence:
file:human/HMGCR/HMGCR-uniprot.txt
the rate-limiting step in the synthesis of
GO:0050709 negative regulation of protein secretion
IEA
GO_REF:0000107
MARK AS OVER ANNOTATED
Summary: Electronic transfer (Ensembl Compara) from the mouse ortholog (Q01237) of a role in negatively regulating protein secretion. Indirect downstream effect, not a direct HMGCR function.
Reason: As with the protein-catabolism annotation, this is an orthology-transferred, indirect regulatory role rather than the enzyme's core function. Flagged as over-annotated.
Supporting Evidence:
file:human/HMGCR/HMGCR-uniprot.txt
the rate-limiting step in the synthesis of
GO:1900222 negative regulation of amyloid-beta clearance
IEA
GO_REF:0000107
MARK AS OVER ANNOTATED
Summary: Electronic transfer (Ensembl Compara) from the mouse ortholog (Q01237) of a role in negatively regulating amyloid-beta clearance. A highly indirect, tissue/context dependent effect linked to cholesterol metabolism, not a direct HMGCR function.
Reason: Very indirect, downstream neurobiological effect transferred by orthology; far removed from HMGCR's catalytic role in the mevalonate pathway. Flagged as over-annotated rather than removed given it is an electronic ortholog transfer.
Supporting Evidence:
file:human/HMGCR/HMGCR-uniprot.txt
the rate-limiting step in the synthesis of
GO:0005789 endoplasmic reticulum membrane
IPI
PMID:10698924
Crystal structure of the catalytic portion of human HMG-CoA ...
ACCEPT
Summary: ComplexPortal-assigned ER membrane location for HMGCR. Consistent with the enzyme being a polytopic ER membrane protein whose catalytic domain projects into the cytosol.
Reason: ER membrane is the primary, well-established location of HMGCR; corroborated by experimental subcellular-location and topology data.
Supporting Evidence:
file:human/HMGCR/HMGCR-uniprot.txt
Endoplasmic reticulum membrane
GO:0006695 cholesterol biosynthetic process
IDA
PMID:23063590
Artemisinic acid inhibits melanogenesis through downregulati...
ACCEPT
Summary: Direct assignment of HMGCR to cholesterol biosynthesis. HMGCR catalyzes the rate-limiting mevalonate-producing step of cholesterol synthesis; the cited study links HMGCR-dependent cholesterol synthesis to melanogenesis.
Reason: Correct and central: cholesterol biosynthesis is the best-known role of the mevalonate pathway, and HMGCR is its rate-limiting step. This is a core biological process for the gene.
Supporting Evidence:
PMID:21357570
is the rate-controlling enzyme of
PMID:36745799
facilitates the rate-limiting step in cholesterol synthesis
GO:0008299 isoprenoid biosynthetic process
NAS
PMID:18540668
Thermodynamic and structure guided design of statin based in...
ACCEPT
Summary: Non-traceable author-statement assignment of HMGCR to isoprenoid biosynthesis, from a statin-inhibitor structure/design paper that treats HMGCR as the mevalonate-pathway enzyme.
Reason: Correct pathway assignment; HMGCR produces mevalonate for isoprenoid biosynthesis. Redundant with the IBA/IEA annotations to the same term.
Supporting Evidence:
PMID:18540668
statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) inhibitors
GO:0004420 hydroxymethylglutaryl-CoA reductase (NADPH) activity
EXP
PMID:36745799
Limb girdle muscular disease caused by HMGCR mutation and st...
ACCEPT
Summary: Experimental demonstration of HMGCR catalytic activity in the context of an LGMDR28 disease variant, with kinetic characterization (KM for HMG-CoA) and statin (pravastatin) inhibition; disease rescued by mevalonolactone.
Reason: Direct experimental support for the core catalytic activity in human HMGCR; strong evidence anchoring GO:0004420 as the core molecular function.
Supporting Evidence:
PMID:36745799
facilitates the rate-limiting step in cholesterol synthesis
GO:0004420 hydroxymethylglutaryl-CoA reductase (NADPH) activity
EXP
PMID:6995544
Multivalent feedback regulation of HMG CoA reductase, a cont...
ACCEPT
Summary: Experimental study of HMGCR as the mevalonate-synthesizing enzyme subject to multivalent feedback regulation, using the competitive inhibitor compactin.
Reason: Classic experimental characterization of the enzyme that synthesizes mevalonate; supports the core catalytic activity and its feedback regulation.
Supporting Evidence:
PMID:6995544
the enzyme that synthesizes mevalonate
GO:0005789 endoplasmic reticulum membrane
EXP
PMID:17180682
Localization of the pre-squalene segment of the isoprenoid b...
ACCEPT
Summary: Experimental subcellular-localization study assigning HMGCR (and the pre-squalene isoprenoid segment) to the ER membrane (and peroxisomes).
Reason: ER membrane is the primary, functionally central location of HMGCR; experimentally supported.
Supporting Evidence:
file:human/HMGCR/HMGCR-uniprot.txt
Endoplasmic reticulum membrane
GO:0042177 negative regulation of protein catabolic process
ISS
GO_REF:0000024
MARK AS OVER ANNOTATED
Summary: Sequence-similarity transfer (from mouse Q01237) of a role in negatively regulating protein catabolism. Same indirect, non-core role as the corresponding IEA annotation.
Reason: Indirect, ortholog-transferred regulatory role that is several steps removed from HMGCR's catalytic function; not a core process. Flagged as over-annotated.
Supporting Evidence:
file:human/HMGCR/HMGCR-uniprot.txt
the rate-limiting step in the synthesis of
GO:0050709 negative regulation of protein secretion
ISS
GO_REF:0000024
MARK AS OVER ANNOTATED
Summary: Sequence-similarity transfer (from mouse Q01237) of a role in negatively regulating protein secretion. Indirect, non-core role.
Reason: Ortholog-transferred, indirect regulatory effect rather than a direct HMGCR function. Flagged as over-annotated.
Supporting Evidence:
file:human/HMGCR/HMGCR-uniprot.txt
the rate-limiting step in the synthesis of
GO:0120225 coenzyme A binding
IDA
PMID:10698924
Crystal structure of the catalytic portion of human HMG-CoA ...
ACCEPT
Summary: Direct structural demonstration that HMGCR binds coenzyme A, from crystal structures of the catalytic domain in complex with HMG-CoA and with HMG + CoA.
Reason: Supported by co-crystal structures; a genuine molecular-function detail of the enzyme's HMG-CoA substrate/CoA interaction. Kept as a supporting (non-primary) molecular function underlying catalysis.
Supporting Evidence:
PMID:10698924
with HMG and CoA, and with HMG, CoA and NADP(+)
GO:0004420 hydroxymethylglutaryl-CoA reductase (NADPH) activity
IDA
PMID:21357570
Epigallocatechin-3-gallate potently inhibits the in vitro ac...
ACCEPT
Summary: Direct in vitro measurement of human HMGCR enzymatic activity (rate-controlling enzyme of cholesterol synthesis) in a kinetic/inhibition study with EGCG.
Reason: Direct experimental support for the core catalytic activity of HMGCR.
Supporting Evidence:
PMID:21357570
is the rate-controlling enzyme of
GO:1900222 negative regulation of amyloid-beta clearance
ISS
GO_REF:0000024
MARK AS OVER ANNOTATED
Summary: Sequence-similarity transfer (from mouse Q01237) of a role in negatively regulating amyloid-beta clearance. Highly indirect, context-dependent effect.
Reason: Very indirect, downstream neurobiological role transferred by orthology; not a core HMGCR function. Flagged as over-annotated.
Supporting Evidence:
file:human/HMGCR/HMGCR-uniprot.txt
the rate-limiting step in the synthesis of
GO:0005789 endoplasmic reticulum membrane
TAS
Reactome:R-HSA-9621410
ACCEPT
Summary: Reactome traceable assignment of HMGCR to the ER membrane (HMGCR gene expression pathway context).
Reason: Consistent with the established ER membrane localization of HMGCR.
Supporting Evidence:
file:human/HMGCR/HMGCR-uniprot.txt
Endoplasmic reticulum membrane
GO:0005789 endoplasmic reticulum membrane
TAS
Reactome:R-HSA-1655826
ACCEPT
Summary: Reactome traceable assignment of HMGCR to the ER membrane (HMGCR expression pathway context).
Reason: Consistent with the established ER membrane localization of HMGCR.
Supporting Evidence:
file:human/HMGCR/HMGCR-uniprot.txt
Endoplasmic reticulum membrane
GO:0005789 endoplasmic reticulum membrane
TAS
Reactome:R-HSA-191352
ACCEPT
Summary: Reactome traceable assignment of HMGCR to the ER membrane in the reaction "HMGCR dimer reduces bHMG-CoA to MVA", the catalytic step of the mevalonate pathway.
Reason: Consistent with the established ER membrane localization of the catalytically active HMGCR dimer.
Supporting Evidence:
file:human/HMGCR/HMGCR-uniprot.txt
Endoplasmic reticulum membrane
GO:0005789 endoplasmic reticulum membrane
TAS
Reactome:R-HSA-9705584
ACCEPT
Summary: Reactome traceable assignment of HMGCR to the ER membrane in the reaction "HMGCR dimer binds statins".
Reason: Consistent with the established ER membrane localization of HMGCR.
Supporting Evidence:
file:human/HMGCR/HMGCR-uniprot.txt
Endoplasmic reticulum membrane
GO:0004420 hydroxymethylglutaryl-CoA reductase (NADPH) activity
IDA
PMID:2991281
Human 3-hydroxy-3-methylglutaryl coenzyme A reductase. Conse...
ACCEPT
Summary: Direct characterization of human HMGCR (isolation and analysis of the full-length cDNA encoding the membrane-bound glycoprotein that regulates cholesterol synthesis), defining the catalytic C-terminal domain.
Reason: Foundational human evidence for the enzyme's catalytic function and its two-domain architecture (membrane + catalytic). Supports GO:0004420 as core.
Supporting Evidence:
PMID:2991281
the membrane-bound glycoprotein that regulates cholesterol synthesis
GO:0005778 peroxisomal membrane
IDA
PMID:17180682
Localization of the pre-squalene segment of the isoprenoid b...
KEEP AS NON CORE
Summary: Experimental (immunofluorescence/isotopic) evidence localizing the pre-squalene isoprenoid segment, including HMGCR, to peroxisomes in human cells.
Reason: This is an experimental annotation and is retained. However, peroxisomal localization of the pre-squalene cholesterol-biosynthetic enzymes is contested in the literature and is secondary to the dominant ER membrane pool that mediates HMGCR's regulated activity. Marked non-core rather than accepted as a primary site.
Supporting Evidence:
PMID:17180682
isoprenoid/cholesterol biosynthetic pathway occur in peroxisomes
GO:0005783 endoplasmic reticulum
IDA
PMID:17180682
Localization of the pre-squalene segment of the isoprenoid b...
ACCEPT
Summary: Experimental localization of HMGCR to the endoplasmic reticulum (parent compartment of the ER membrane where the protein resides).
Reason: Correct; ER is the primary compartment of HMGCR. The more specific ER membrane annotation is preferred for the location detail, but the ER assignment is accurate.
Supporting Evidence:
file:human/HMGCR/HMGCR-uniprot.txt
Endoplasmic reticulum membrane
GO:0005789 endoplasmic reticulum membrane
TAS
PMID:2991281
Human 3-hydroxy-3-methylglutaryl coenzyme A reductase. Conse...
ACCEPT
Summary: Traceable author statement placing HMGCR in the ER membrane, based on the N-terminal membrane domain predicted to span the ER membrane multiple times.
Reason: Consistent with the multi-pass ER membrane topology; ER membrane is the primary HMGCR location.
Supporting Evidence:
PMID:2991281
which is predicted to span
GO:0070402 NADPH binding
IDA
PMID:10698924
Crystal structure of the catalytic portion of human HMG-CoA ...
ACCEPT
Summary: Direct structural demonstration that HMGCR binds NADP(H), from crystal structures of the catalytic domain in complex with HMG, CoA and NADP(+).
Reason: Supported by co-crystal structures; NADPH is the obligate cofactor of the reduction reaction. Kept as a supporting molecular function underlying catalysis; more specific than the IEA NADP binding annotation.
Supporting Evidence:
PMID:10698924
with HMG, CoA and NADP(+)

Core Functions

NADPH-dependent reduction of (3S)-3-hydroxy-3-methylglutaryl-CoA to (R)-mevalonate and CoA, the rate-limiting and committed step of the mevalonate pathway, performed by the cytosolic catalytic domain of HMGCR (assembled as homodimers/homotetramers) at the endoplasmic reticulum membrane.

Supporting Evidence:
  • PMID:10698924
    the committed step in the biosynthesis of sterols and isoprenoids
  • PMID:36745799
    facilitates the rate-limiting step in cholesterol synthesis

Production of mevalonate as the precursor for non-sterol isoprenoids (dolichol, ubiquinone, and farnesyl/geranylgeranyl prenyl groups), placing HMGCR at the head of isoprenoid biosynthesis in addition to cholesterol/sterol synthesis.

Supporting Evidence:
  • PMID:10698924
    the committed step in the biosynthesis of sterols and isoprenoids

References

Gene Ontology annotation through association of InterPro records with GO terms
Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
Combined Automated Annotation using Multiple IEA Methods
file:human/HMGCR/HMGCR-uniprot.txt
UniProtKB entry P04035 (HMDH_HUMAN), 3-hydroxy-3-methylglutaryl-coenzyme A reductase
Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis.
Localization of the pre-squalene segment of the isoprenoid biosynthetic pathway in mammalian peroxisomes.
Thermodynamic and structure guided design of statin based inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Epigallocatechin-3-gallate potently inhibits the in vitro activity of hydroxy-3-methyl-glutaryl-CoA reductase.
Artemisinic acid inhibits melanogenesis through downregulation of C/EBP α-dependent expression of HMG-CoA reductase gene.
The UBIAD1 prenyltransferase links menaquinone-4 [corrected] synthesis to cholesterol metabolic enzymes.
Human 3-hydroxy-3-methylglutaryl coenzyme A reductase. Conserved domains responsible for catalytic activity and sterol-regulated degradation.
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
Limb girdle muscular disease caused by HMGCR mutation and statin myopathy treatable with mevalonolactone.
Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth.
Reactome:R-HSA-1655826
Expression of 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase (HMGCR)
Reactome:R-HSA-191352
HMGCR dimer reduces bHMG-CoA to MVA
Reactome:R-HSA-9621410
HMGCR gene expression
Reactome:R-HSA-9705584
HMGCR dimer binds statins

Suggested Questions for Experts

Q: Is the reported peroxisomal pool of HMGCR functionally significant, or is HMGCR activity essentially entirely ER-membrane-based in human cells?

Q: To what extent do the orthology-transferred regulatory roles (negative regulation of protein secretion/catabolism, amyloid-beta clearance) reflect direct HMGCR effects versus indirect consequences of altered cholesterol/isoprenoid levels?

Suggested Experiments

Experiment: Quantify the relative contribution of ER versus peroxisomal HMGCR to cellular mevalonate/cholesterol synthesis using compartment-targeted assays or organelle fractionation combined with isotopic flux analysis.

Experiment: Structurally and enzymatically characterize LGMDR28 disease variants to relate catalytic/thermal-stability defects to muscle phenotype and mevalonolactone rescue.

📚 Additional Documentation

Notes

(HMGCR-notes.md)

HMGCR (human, UniProtKB:P04035) — review notes

Deep research note: falcon provider is out of credits (HTTP 402); no
-deep-research-falcon.md was generated. This review is grounded in the UniProt
record (HMGCR-uniprot.txt), the seeded GOA (HMGCR-goa.tsv), and the cached
publications/PMID_*.md / reactome/R-HSA-*.md entries.

Core biology

HMGCR is 3-hydroxy-3-methylglutaryl-coenzyme A reductase (NADPH) (EC 1.1.1.34),
the rate-limiting, committed enzyme of the mevalonate pathway. It catalyzes the
NADPH-dependent four-electron reduction of (3S)-HMG-CoA to (R)-mevalonate + CoA
(two-step reaction consuming 2 NADPH).

  • Catalytic reaction (UniProt CATALYTIC ACTIVITY): "(R)-mevalonate + 2 NADP(+) + CoA
    = (3S)-3-hydroxy-3-methylglutaryl-CoA + 2 NADPH + 2 H(+)" (Rhea:RHEA:15989; EC=1.1.1.34).
  • PMID:10698924
  • PMID:6995544 — rate/feedback.
  • PMID:21357570
  • PMID:36745799 — plus LGMDR28 disease + rescue by mevalonolactone.

Structure / domains

  • Polytopic ER membrane protein (multi-pass); 888 aa. N-terminal membrane domain (8 TM helices,
    residues ~1-339) contains the sterol-sensing domain (SSD, 61-218) with the INSIG-binding motif
    (75-78). C-terminal cytosolic domain (~426-888) is catalytic.
  • PMID:2991281;
    N-terminal domain "which is predicted to span the endoplasmic reticulum membrane seven times"
    and "mediates accelerated degradation of reductase in the presence of sterols."
  • Crystal structures of the catalytic portion (422-888): homotetramer/homodimer; active site with
    CoA, NADP(+), and HMG bound. PMID:10698924
    UniProt BINDING: CoA (565-571, 720-722, 865-866), NADP(+) (626-628, 653-661, 870-871).

Regulation / degradation

  • Sterol-accelerated ERAD: sterols promote HMGCR binding (via SSD) to INSIG1/INSIG2, recruiting
    ubiquitin ligases (AMFR/gp78, RNF139/TRC8, RNF145), ubiquitination (Lys-248 main site) and
    proteasomal degradation. SREBP/SCAP axis controls transcription. Feedback by sterol + nonsterol
    mevalonate-derived signals PMID:6995544.
  • Target of statins (competitive inhibitors) — cholesterol-lowering drugs [PMID:18540668,
    PMID:10698924 abstract; Reactome R-HSA-9705584].

Localization

  • ER membrane (primary): UniProt SUBCELLULAR LOCATION "Endoplasmic reticulum membrane"; also
    PMID:17180682 localizes pre-squalene isoprenoid segment (incl. HMGCR) to peroxisomes:
    "isoprenoid/cholesterol biosynthetic pathway occur in peroxisomes". Peroxisomal localization of
    cholesterol-biosynthesis enzymes is contested in the literature; ER is the well-established site.

Interactions

  • UBIAD1 [PMID:23169578 "interacts with HMGCR and SOAT1, enzymes catalyzing cholesterol synthesis
    and" ... "using yeast two-hybrid screening and immunoprecipitation"] — reported IPI (protein binding).
  • High-throughput interactome (BioPlex) PMID:33961781 — AP-MS network; the IPI to UBIAD1 (Q9Y5Z9)
    here is a bare protein-binding assignment.

Disease

  • Autosomal recessive limb-girdle muscular dystrophy 28 (LGMDR28) from bi-allelic HMGCR variants
    [PMID:36745799, PMID:37167966]; statin-associated immune-mediated necrotizing myopathy involves
    anti-HMGCR autoantibodies (background).

Curation decisions summary

  • MF GO:0004420 (HMG-CoA reductase NADPH activity): core; multiple IDA/EXP + IBA/IEA → ACCEPT.
  • GO:0120225 coenzyme A binding, GO:0070402 NADPH binding: IDA from crystal structure → ACCEPT (molecular detail of catalysis).
  • GO:0050661 NADP binding (IEA/InterPro): redundant, more general than GO:0070402 IDA → KEEP_AS_NON_CORE.
  • GO:0016616 (parent oxidoreductase term, IEA): too general vs GO:0004420 → MARK_AS_OVER_ANNOTATED.
  • BP: GO:0006695 cholesterol biosynthetic process (IDA), GO:0016126 sterol, GO:0008299 isoprenoid → ACCEPT (core pathway).
  • GO:0015936 coenzyme A metabolic process (IEA/InterPro): CoA is a product, not the pathway HMGCR is "in" — over-annotation → MARK_AS_OVER_ANNOTATED.
  • CC: GO:0005789 ER membrane (many lines, EXP/IDA/IBA/IEA/TAS) → ACCEPT; GO:0005783 ER (IDA) ACCEPT.
  • GO:0005778 peroxisomal membrane (IDA PMID:17180682, IBA, IEA): keep experimental IDA but non-core (contested) → KEEP_AS_NON_CORE; IEA SubCell → KEEP_AS_NON_CORE; IBA → KEEP_AS_NON_CORE.
  • GO:0005515 protein binding IPIs (UBIAD1) → MARK_AS_OVER_ANNOTATED (per policy, not REMOVE).
  • GO:0042177 neg reg protein catabolic, GO:0050709 neg reg protein secretion, GO:1900222 neg reg amyloid-beta clearance
    (ISS/IEA from mouse Q01237 ortholog): these are indirect/pleiotropic downstream effects of cholesterol
    pathway, not HMGCR molecular function → MARK_AS_OVER_ANNOTATED (ISS/IEA electronic transfers, weak).

📄 View Raw YAML

id: P04035
gene_symbol: HMGCR
product_type: PROTEIN
status: INITIALIZED
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  HMGCR encodes 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase;
  EC 1.1.1.34), the rate-limiting and committed enzyme of the mevalonate pathway.
  It catalyzes the NADPH-dependent reduction of (3S)-3-hydroxy-3-methylglutaryl-CoA
  (HMG-CoA) to (R)-mevalonate and CoA, a two-step, four-electron reaction consuming
  two molecules of NADPH. Mevalonate is the precursor for cholesterol, dolichol,
  ubiquinone and the prenyl groups (farnesyl/geranylgeranyl) used in protein
  prenylation, so HMGCR sits at the head of sterol and non-sterol isoprenoid
  biosynthesis. HMGCR is a polytopic (multi-pass) endoplasmic reticulum membrane
  protein of 888 residues: its N-terminal membrane-anchored region contains a
  sterol-sensing domain that, together with INSIG proteins and SREBP/SCAP, mediates
  sterol-accelerated ubiquitination and ER-associated degradation and feedback
  regulation of the enzyme, while the C-terminal cytosolic domain is catalytic and
  assembles into homodimers/homotetramers. HMGCR is the molecular target of the
  statin class of cholesterol-lowering drugs, which act as competitive inhibitors
  at the HMG-CoA/cofactor site. Bi-allelic loss-of-function HMGCR variants cause an
  autosomal-recessive limb-girdle muscular dystrophy (LGMDR28).
alternative_products:
- name: 1 (HMGCR-1a {ECO:0000303|PubMed:22989091})
  id: P04035-1
- name: 2 (HMGCR-1c {ECO:0000303|PubMed:22989091})
  id: P04035-2
  sequence_note: VSP_002207
- name: 3 (HMGCR-1b {ECO:0000303|PubMed:22989091})
  id: P04035-3
  sequence_note: VSP_046492
existing_annotations:
- term:
    id: GO:0004420
    label: hydroxymethylglutaryl-CoA reductase (NADPH) activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: enables
  review:
    summary: >-
      Phylogenetic (IBA) assignment of the defining molecular function of HMGCR:
      NADPH-dependent reduction of HMG-CoA to mevalonate. This is the well-established
      catalytic activity of the enzyme, supported by direct human enzymology and
      crystallography, and is the core function of the gene.
    action: ACCEPT
    reason: >-
      Correct and specific. HMGCR is the rate-limiting enzyme of the mevalonate
      pathway; the IBA is corroborated by human experimental evidence.
    supported_by:
    - reference_id: PMID:10698924
      supporting_text: >-
        catalyzes the formation of
    - reference_id: PMID:10698924
      supporting_text: >-
        mevalonate, the committed step
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: is_active_in
  review:
    summary: >-
      Phylogenetic assignment placing HMGCR activity in the ER membrane, consistent
      with its being a polytopic ER membrane protein anchored by an N-terminal
      multi-pass membrane domain.
    action: ACCEPT
    reason: >-
      ER membrane is the primary, well-established site of HMGCR; supported by human
      subcellular-location data and the multi-pass membrane topology in UniProt.
    supported_by:
    - reference_id: PMID:2991281
      supporting_text: >-
        the membrane-bound glycoprotein that regulates cholesterol synthesis
    - reference_id: file:human/HMGCR/HMGCR-uniprot.txt
      supporting_text: Endoplasmic reticulum membrane
- term:
    id: GO:0016126
    label: sterol biosynthetic process
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: >-
      Phylogenetic assignment of HMGCR to sterol biosynthesis. As the rate-limiting
      step producing mevalonate, HMGCR is required for cholesterol/sterol synthesis.
    action: ACCEPT
    reason: >-
      Accurate pathway assignment; mevalonate is the obligate precursor of sterols.
      Retained as a core biological process, alongside the more specific cholesterol
      biosynthetic process annotation.
    supported_by:
    - reference_id: PMID:10698924
      supporting_text: >-
        the committed step in the biosynthesis of sterols and isoprenoids
- term:
    id: GO:0008299
    label: isoprenoid biosynthetic process
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: >-
      Phylogenetic assignment of HMGCR to isoprenoid biosynthesis. Mevalonate is the
      precursor of all non-sterol isoprenoids (dolichol, ubiquinone, prenyl groups)
      as well as sterols.
    action: ACCEPT
    reason: >-
      Correct: HMGCR is the committed step producing mevalonate for both sterol and
      non-sterol isoprenoid branches.
    supported_by:
    - reference_id: PMID:10698924
      supporting_text: >-
        the committed step in the biosynthesis of sterols and isoprenoids
- term:
    id: GO:0005778
    label: peroxisomal membrane
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: is_active_in
  review:
    summary: >-
      Phylogenetic assignment of HMGCR to the peroxisomal membrane. A peroxisomal
      pool of pre-squalene mevalonate-pathway enzymes has been reported, but this
      localization is contested and secondary to the dominant ER membrane pool.
    action: KEEP_AS_NON_CORE
    reason: >-
      Retained because there is experimental support for a peroxisomal pool of
      pre-squalene isoprenoid enzymes, but peroxisomal localization of these enzymes
      is disputed in the literature and is not the core site of HMGCR action, which
      is the ER membrane. Marked non-core rather than accepted as a primary location.
    supported_by:
    - reference_id: PMID:17180682
      supporting_text: >-
        isoprenoid/cholesterol biosynthetic pathway occur in peroxisomes
- term:
    id: GO:0004420
    label: hydroxymethylglutaryl-CoA reductase (NADPH) activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: >-
      Electronic (InterPro/EC/RHEA-based) assignment of the core catalytic activity.
      Redundant with the experimental and IBA annotations to the same term.
    action: ACCEPT
    reason: >-
      Correct core molecular function, mapped from HMG-CoA reductase InterPro domains,
      EC 1.1.1.34 and RHEA:15989. Consistent with all experimental evidence.
    supported_by:
    - reference_id: file:human/HMGCR/HMGCR-uniprot.txt
      supporting_text: the rate-limiting step in the synthesis of
- term:
    id: GO:0005778
    label: peroxisomal membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  qualifier: located_in
  review:
    summary: >-
      UniProt Subcellular-Location keyword mapping to peroxisomal membrane, reflecting
      the reported (contested) peroxisomal pool of pre-squalene isoprenoid enzymes.
    action: KEEP_AS_NON_CORE
    reason: >-
      Consistent with the UniProt "Peroxisome membrane" subcellular location, itself
      based on PMID:17180682. Kept as a non-core location; the dominant and functionally
      central site of HMGCR is the ER membrane.
    supported_by:
    - reference_id: file:human/HMGCR/HMGCR-uniprot.txt
      supporting_text: Peroxisome membrane
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: located_in
  review:
    summary: >-
      Electronic assignment of the primary ER membrane location, mapped from InterPro
      (metazoan HMGCR) and the UniProt subcellular-location keyword.
    action: ACCEPT
    reason: >-
      ER membrane is the established primary location of HMGCR; the electronic mapping
      is correct and redundant with the experimental annotations.
    supported_by:
    - reference_id: file:human/HMGCR/HMGCR-uniprot.txt
      supporting_text: Endoplasmic reticulum membrane
- term:
    id: GO:0008299
    label: isoprenoid biosynthetic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: involved_in
  review:
    summary: >-
      InterPro2GO electronic mapping to isoprenoid biosynthesis from the HMG-CoA
      reductase domains. Correct pathway context for the mevalonate-producing step.
    action: ACCEPT
    reason: >-
      Correct: HMGCR produces mevalonate, the precursor of all isoprenoids. Redundant
      with the IBA annotation to the same term.
    supported_by:
    - reference_id: PMID:10698924
      supporting_text: >-
        the committed step in the biosynthesis of sterols and isoprenoids
- term:
    id: GO:0015936
    label: coenzyme A metabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: involved_in
  review:
    summary: >-
      InterPro2GO electronic mapping to coenzyme A metabolic process, triggered by the
      CoA-binding/substrate-binding domains. HMGCR uses HMG-CoA as substrate and
      releases CoA, but it is not a component of a coenzyme A metabolic pathway.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Over-annotation from a domain-to-GO rule. CoA is released as a product of the
      HMGCR reaction (its acyl-CoA substrate is reduced), but HMGCR does not participate
      in coenzyme A biosynthesis or turnover as a metabolic process. The molecular-level
      CoA involvement is more precisely captured by the coenzyme A binding (GO:0120225)
      annotation.
    supported_by:
    - reference_id: file:human/HMGCR/HMGCR-uniprot.txt
      supporting_text: the rate-limiting step in the synthesis of
- term:
    id: GO:0016616
    label: oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP
      as acceptor
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: enables
  review:
    summary: >-
      InterPro2GO electronic mapping to a general oxidoreductase parent term. HMGCR is
      an oxidoreductase acting with NADPH, but this term is far less specific than the
      exact activity GO:0004420.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Grandparent of the precise, well-supported GO:0004420 hydroxymethylglutaryl-CoA
      reductase (NADPH) activity. It is not wrong but is uninformative given the specific
      term is annotated; treated as an over-general over-annotation rather than removed.
    supported_by:
    - reference_id: PMID:10698924
      supporting_text: >-
        catalyzes the formation of
- term:
    id: GO:0050661
    label: NADP binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: enables
  review:
    summary: >-
      InterPro2GO electronic mapping to NADP binding. HMGCR binds NADP(H) as its redox
      cofactor; a more specific NADPH binding (GO:0070402) annotation with direct
      structural evidence also exists.
    action: KEEP_AS_NON_CORE
    reason: >-
      Correct at the cofactor level but redundant with and less specific than the
      structure-based GO:0070402 NADPH binding IDA. Kept as non-core supporting molecular
      detail rather than a core function.
    supported_by:
    - reference_id: file:human/HMGCR/HMGCR-uniprot.txt
      supporting_text: the rate-limiting step in the synthesis of
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:23169578
  qualifier: enables
  review:
    summary: >-
      IPI protein-binding annotation supported by a physical interaction between HMGCR
      and the prenyltransferase UBIAD1 (yeast two-hybrid plus immunoprecipitation).
      The identifier is correct but the GO term is uninformative.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Bare "protein binding" (GO:0005515) does not convey a specific molecular function.
      The underlying UBIAD1 interaction is real, but per curation guidelines this
      generic term is flagged as an over-annotation rather than a core function; it is
      not removed because the experimental interaction is genuine.
    supported_by:
    - reference_id: PMID:23169578
      supporting_text: >-
        interacts with HMGCR and SOAT1, enzymes catalyzing cholesterol synthesis and
    - reference_id: PMID:23169578
      supporting_text: using yeast two-hybrid screening and immunoprecipitation
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:33961781
  qualifier: enables
  review:
    summary: >-
      IPI protein-binding annotation from a proteome-scale affinity-purification/mass
      spectrometry interactome study (BioPlex). Generic binding term with no specific
      molecular-function content.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      High-throughput AP-MS interaction; the "protein binding" (GO:0005515) term is
      uninformative about molecular function. Retained (not removed) as a genuine
      high-throughput interaction but flagged as over-annotated per curation guidelines.
    supported_by:
    - reference_id: PMID:33961781
      supporting_text: >-
        Through affinity-purification mass spectrometry, we have created two
        proteome-scale, cell-line-specific interaction networks.
- term:
    id: GO:0042177
    label: negative regulation of protein catabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: >-
      Electronic transfer (Ensembl Compara) from the mouse ortholog (Q01237) of a role
      in negatively regulating protein catabolism. This is an indirect, downstream
      consequence of mevalonate-pathway output rather than a direct HMGCR function.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Not a direct molecular activity or process of HMGCR; it is an orthology-transferred
      regulatory effect several steps removed from the enzyme's catalytic role. Treated
      as an over-annotation rather than removed, since it is an electronic ortholog
      transfer that may reflect a real but indirect pleiotropic effect.
    supported_by:
    - reference_id: file:human/HMGCR/HMGCR-uniprot.txt
      supporting_text: the rate-limiting step in the synthesis of
- term:
    id: GO:0050709
    label: negative regulation of protein secretion
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: >-
      Electronic transfer (Ensembl Compara) from the mouse ortholog (Q01237) of a role
      in negatively regulating protein secretion. Indirect downstream effect, not a
      direct HMGCR function.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      As with the protein-catabolism annotation, this is an orthology-transferred,
      indirect regulatory role rather than the enzyme's core function. Flagged as
      over-annotated.
    supported_by:
    - reference_id: file:human/HMGCR/HMGCR-uniprot.txt
      supporting_text: the rate-limiting step in the synthesis of
- term:
    id: GO:1900222
    label: negative regulation of amyloid-beta clearance
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: >-
      Electronic transfer (Ensembl Compara) from the mouse ortholog (Q01237) of a role
      in negatively regulating amyloid-beta clearance. A highly indirect, tissue/context
      dependent effect linked to cholesterol metabolism, not a direct HMGCR function.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Very indirect, downstream neurobiological effect transferred by orthology; far
      removed from HMGCR's catalytic role in the mevalonate pathway. Flagged as
      over-annotated rather than removed given it is an electronic ortholog transfer.
    supported_by:
    - reference_id: file:human/HMGCR/HMGCR-uniprot.txt
      supporting_text: the rate-limiting step in the synthesis of
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: IPI
  original_reference_id: PMID:10698924
  qualifier: located_in
  review:
    summary: >-
      ComplexPortal-assigned ER membrane location for HMGCR. Consistent with the
      enzyme being a polytopic ER membrane protein whose catalytic domain projects
      into the cytosol.
    action: ACCEPT
    reason: >-
      ER membrane is the primary, well-established location of HMGCR; corroborated by
      experimental subcellular-location and topology data.
    supported_by:
    - reference_id: file:human/HMGCR/HMGCR-uniprot.txt
      supporting_text: Endoplasmic reticulum membrane
- term:
    id: GO:0006695
    label: cholesterol biosynthetic process
  evidence_type: IDA
  original_reference_id: PMID:23063590
  qualifier: involved_in
  review:
    summary: >-
      Direct assignment of HMGCR to cholesterol biosynthesis. HMGCR catalyzes the
      rate-limiting mevalonate-producing step of cholesterol synthesis; the cited study
      links HMGCR-dependent cholesterol synthesis to melanogenesis.
    action: ACCEPT
    reason: >-
      Correct and central: cholesterol biosynthesis is the best-known role of the
      mevalonate pathway, and HMGCR is its rate-limiting step. This is a core biological
      process for the gene.
    supported_by:
    - reference_id: PMID:21357570
      supporting_text: >-
        is the rate-controlling enzyme of
    - reference_id: PMID:36745799
      supporting_text: >-
        facilitates the rate-limiting step in cholesterol synthesis
- term:
    id: GO:0008299
    label: isoprenoid biosynthetic process
  evidence_type: NAS
  original_reference_id: PMID:18540668
  qualifier: involved_in
  review:
    summary: >-
      Non-traceable author-statement assignment of HMGCR to isoprenoid biosynthesis,
      from a statin-inhibitor structure/design paper that treats HMGCR as the
      mevalonate-pathway enzyme.
    action: ACCEPT
    reason: >-
      Correct pathway assignment; HMGCR produces mevalonate for isoprenoid biosynthesis.
      Redundant with the IBA/IEA annotations to the same term.
    supported_by:
    - reference_id: PMID:18540668
      supporting_text: >-
        statins, 3-hydroxy-3-methylglutaryl
        coenzyme A reductase (HMGR) inhibitors
- term:
    id: GO:0004420
    label: hydroxymethylglutaryl-CoA reductase (NADPH) activity
  evidence_type: EXP
  original_reference_id: PMID:36745799
  qualifier: enables
  review:
    summary: >-
      Experimental demonstration of HMGCR catalytic activity in the context of an
      LGMDR28 disease variant, with kinetic characterization (KM for HMG-CoA) and
      statin (pravastatin) inhibition; disease rescued by mevalonolactone.
    action: ACCEPT
    reason: >-
      Direct experimental support for the core catalytic activity in human HMGCR;
      strong evidence anchoring GO:0004420 as the core molecular function.
    supported_by:
    - reference_id: PMID:36745799
      supporting_text: >-
        facilitates the rate-limiting step in cholesterol synthesis
- term:
    id: GO:0004420
    label: hydroxymethylglutaryl-CoA reductase (NADPH) activity
  evidence_type: EXP
  original_reference_id: PMID:6995544
  qualifier: enables
  review:
    summary: >-
      Experimental study of HMGCR as the mevalonate-synthesizing enzyme subject to
      multivalent feedback regulation, using the competitive inhibitor compactin.
    action: ACCEPT
    reason: >-
      Classic experimental characterization of the enzyme that synthesizes mevalonate;
      supports the core catalytic activity and its feedback regulation.
    supported_by:
    - reference_id: PMID:6995544
      supporting_text: >-
        the enzyme that synthesizes mevalonate
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: EXP
  original_reference_id: PMID:17180682
  qualifier: located_in
  review:
    summary: >-
      Experimental subcellular-localization study assigning HMGCR (and the pre-squalene
      isoprenoid segment) to the ER membrane (and peroxisomes).
    action: ACCEPT
    reason: >-
      ER membrane is the primary, functionally central location of HMGCR; experimentally
      supported.
    supported_by:
    - reference_id: file:human/HMGCR/HMGCR-uniprot.txt
      supporting_text: Endoplasmic reticulum membrane
- term:
    id: GO:0042177
    label: negative regulation of protein catabolic process
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  qualifier: involved_in
  review:
    summary: >-
      Sequence-similarity transfer (from mouse Q01237) of a role in negatively
      regulating protein catabolism. Same indirect, non-core role as the corresponding
      IEA annotation.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Indirect, ortholog-transferred regulatory role that is several steps removed from
      HMGCR's catalytic function; not a core process. Flagged as over-annotated.
    supported_by:
    - reference_id: file:human/HMGCR/HMGCR-uniprot.txt
      supporting_text: the rate-limiting step in the synthesis of
- term:
    id: GO:0050709
    label: negative regulation of protein secretion
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  qualifier: involved_in
  review:
    summary: >-
      Sequence-similarity transfer (from mouse Q01237) of a role in negatively
      regulating protein secretion. Indirect, non-core role.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Ortholog-transferred, indirect regulatory effect rather than a direct HMGCR
      function. Flagged as over-annotated.
    supported_by:
    - reference_id: file:human/HMGCR/HMGCR-uniprot.txt
      supporting_text: the rate-limiting step in the synthesis of
- term:
    id: GO:0120225
    label: coenzyme A binding
  evidence_type: IDA
  original_reference_id: PMID:10698924
  qualifier: enables
  review:
    summary: >-
      Direct structural demonstration that HMGCR binds coenzyme A, from crystal
      structures of the catalytic domain in complex with HMG-CoA and with HMG + CoA.
    action: ACCEPT
    reason: >-
      Supported by co-crystal structures; a genuine molecular-function detail of the
      enzyme's HMG-CoA substrate/CoA interaction. Kept as a supporting (non-primary)
      molecular function underlying catalysis.
    supported_by:
    - reference_id: PMID:10698924
      supporting_text: >-
        with HMG and CoA, and with HMG, CoA and NADP(+)
- term:
    id: GO:0004420
    label: hydroxymethylglutaryl-CoA reductase (NADPH) activity
  evidence_type: IDA
  original_reference_id: PMID:21357570
  qualifier: enables
  review:
    summary: >-
      Direct in vitro measurement of human HMGCR enzymatic activity (rate-controlling
      enzyme of cholesterol synthesis) in a kinetic/inhibition study with EGCG.
    action: ACCEPT
    reason: >-
      Direct experimental support for the core catalytic activity of HMGCR.
    supported_by:
    - reference_id: PMID:21357570
      supporting_text: >-
        is the rate-controlling enzyme of
- term:
    id: GO:1900222
    label: negative regulation of amyloid-beta clearance
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  qualifier: involved_in
  review:
    summary: >-
      Sequence-similarity transfer (from mouse Q01237) of a role in negatively
      regulating amyloid-beta clearance. Highly indirect, context-dependent effect.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Very indirect, downstream neurobiological role transferred by orthology; not a
      core HMGCR function. Flagged as over-annotated.
    supported_by:
    - reference_id: file:human/HMGCR/HMGCR-uniprot.txt
      supporting_text: the rate-limiting step in the synthesis of
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9621410
  qualifier: located_in
  review:
    summary: >-
      Reactome traceable assignment of HMGCR to the ER membrane (HMGCR gene expression
      pathway context).
    action: ACCEPT
    reason: >-
      Consistent with the established ER membrane localization of HMGCR.
    supported_by:
    - reference_id: file:human/HMGCR/HMGCR-uniprot.txt
      supporting_text: Endoplasmic reticulum membrane
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-1655826
  qualifier: located_in
  review:
    summary: >-
      Reactome traceable assignment of HMGCR to the ER membrane (HMGCR expression
      pathway context).
    action: ACCEPT
    reason: >-
      Consistent with the established ER membrane localization of HMGCR.
    supported_by:
    - reference_id: file:human/HMGCR/HMGCR-uniprot.txt
      supporting_text: Endoplasmic reticulum membrane
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-191352
  qualifier: located_in
  review:
    summary: >-
      Reactome traceable assignment of HMGCR to the ER membrane in the reaction
      "HMGCR dimer reduces bHMG-CoA to MVA", the catalytic step of the mevalonate
      pathway.
    action: ACCEPT
    reason: >-
      Consistent with the established ER membrane localization of the catalytically
      active HMGCR dimer.
    supported_by:
    - reference_id: file:human/HMGCR/HMGCR-uniprot.txt
      supporting_text: Endoplasmic reticulum membrane
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9705584
  qualifier: located_in
  review:
    summary: >-
      Reactome traceable assignment of HMGCR to the ER membrane in the reaction
      "HMGCR dimer binds statins".
    action: ACCEPT
    reason: >-
      Consistent with the established ER membrane localization of HMGCR.
    supported_by:
    - reference_id: file:human/HMGCR/HMGCR-uniprot.txt
      supporting_text: Endoplasmic reticulum membrane
- term:
    id: GO:0004420
    label: hydroxymethylglutaryl-CoA reductase (NADPH) activity
  evidence_type: IDA
  original_reference_id: PMID:2991281
  qualifier: enables
  review:
    summary: >-
      Direct characterization of human HMGCR (isolation and analysis of the full-length
      cDNA encoding the membrane-bound glycoprotein that regulates cholesterol synthesis),
      defining the catalytic C-terminal domain.
    action: ACCEPT
    reason: >-
      Foundational human evidence for the enzyme's catalytic function and its two-domain
      architecture (membrane + catalytic). Supports GO:0004420 as core.
    supported_by:
    - reference_id: PMID:2991281
      supporting_text: >-
        the membrane-bound glycoprotein that regulates cholesterol synthesis
- term:
    id: GO:0005778
    label: peroxisomal membrane
  evidence_type: IDA
  original_reference_id: PMID:17180682
  qualifier: located_in
  review:
    summary: >-
      Experimental (immunofluorescence/isotopic) evidence localizing the pre-squalene
      isoprenoid segment, including HMGCR, to peroxisomes in human cells.
    action: KEEP_AS_NON_CORE
    reason: >-
      This is an experimental annotation and is retained. However, peroxisomal
      localization of the pre-squalene cholesterol-biosynthetic enzymes is contested
      in the literature and is secondary to the dominant ER membrane pool that mediates
      HMGCR's regulated activity. Marked non-core rather than accepted as a primary site.
    supported_by:
    - reference_id: PMID:17180682
      supporting_text: >-
        isoprenoid/cholesterol biosynthetic pathway occur in peroxisomes
- term:
    id: GO:0005783
    label: endoplasmic reticulum
  evidence_type: IDA
  original_reference_id: PMID:17180682
  qualifier: located_in
  review:
    summary: >-
      Experimental localization of HMGCR to the endoplasmic reticulum (parent compartment
      of the ER membrane where the protein resides).
    action: ACCEPT
    reason: >-
      Correct; ER is the primary compartment of HMGCR. The more specific ER membrane
      annotation is preferred for the location detail, but the ER assignment is accurate.
    supported_by:
    - reference_id: file:human/HMGCR/HMGCR-uniprot.txt
      supporting_text: Endoplasmic reticulum membrane
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: TAS
  original_reference_id: PMID:2991281
  qualifier: located_in
  review:
    summary: >-
      Traceable author statement placing HMGCR in the ER membrane, based on the
      N-terminal membrane domain predicted to span the ER membrane multiple times.
    action: ACCEPT
    reason: >-
      Consistent with the multi-pass ER membrane topology; ER membrane is the primary
      HMGCR location.
    supported_by:
    - reference_id: PMID:2991281
      supporting_text: >-
        which is predicted to span
- term:
    id: GO:0070402
    label: NADPH binding
  evidence_type: IDA
  original_reference_id: PMID:10698924
  qualifier: enables
  review:
    summary: >-
      Direct structural demonstration that HMGCR binds NADP(H), from crystal structures
      of the catalytic domain in complex with HMG, CoA and NADP(+).
    action: ACCEPT
    reason: >-
      Supported by co-crystal structures; NADPH is the obligate cofactor of the reduction
      reaction. Kept as a supporting molecular function underlying catalysis; more
      specific than the IEA NADP binding annotation.
    supported_by:
    - reference_id: PMID:10698924
      supporting_text: >-
        with HMG, CoA and NADP(+)
core_functions:
- description: >-
    NADPH-dependent reduction of (3S)-3-hydroxy-3-methylglutaryl-CoA to (R)-mevalonate
    and CoA, the rate-limiting and committed step of the mevalonate pathway, performed
    by the cytosolic catalytic domain of HMGCR (assembled as homodimers/homotetramers)
    at the endoplasmic reticulum membrane.
  molecular_function:
    id: GO:0004420
    label: hydroxymethylglutaryl-CoA reductase (NADPH) activity
  directly_involved_in:
  - id: GO:0006695
    label: cholesterol biosynthetic process
  locations:
  - id: GO:0005789
    label: endoplasmic reticulum membrane
  supported_by:
  - reference_id: PMID:10698924
    supporting_text: >-
      the committed step in the biosynthesis of sterols and isoprenoids
  - reference_id: PMID:36745799
    supporting_text: >-
      facilitates the rate-limiting step in cholesterol synthesis
- description: >-
    Production of mevalonate as the precursor for non-sterol isoprenoids (dolichol,
    ubiquinone, and farnesyl/geranylgeranyl prenyl groups), placing HMGCR at the head
    of isoprenoid biosynthesis in addition to cholesterol/sterol synthesis.
  molecular_function:
    id: GO:0004420
    label: hydroxymethylglutaryl-CoA reductase (NADPH) activity
  directly_involved_in:
  - id: GO:0008299
    label: isoprenoid biosynthetic process
  locations:
  - id: GO:0005789
    label: endoplasmic reticulum membrane
  supported_by:
  - reference_id: PMID:10698924
    supporting_text: >-
      the committed step in the biosynthesis of sterols and isoprenoids
proposed_new_terms: []
suggested_questions:
- question: >-
    Is the reported peroxisomal pool of HMGCR functionally significant, or is HMGCR
    activity essentially entirely ER-membrane-based in human cells?
- question: >-
    To what extent do the orthology-transferred regulatory roles (negative regulation
    of protein secretion/catabolism, amyloid-beta clearance) reflect direct HMGCR
    effects versus indirect consequences of altered cholesterol/isoprenoid levels?
suggested_experiments:
- description: >-
    Quantify the relative contribution of ER versus peroxisomal HMGCR to cellular
    mevalonate/cholesterol synthesis using compartment-targeted assays or organelle
    fractionation combined with isotopic flux analysis.
- description: >-
    Structurally and enzymatically characterize LGMDR28 disease variants to relate
    catalytic/thermal-stability defects to muscle phenotype and mevalonolactone rescue.
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO
    terms
  findings: []
- id: GO_REF:0000024
  title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
    by curator judgment of sequence similarity
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
    vocabulary mapping, accompanied by conservative changes to GO terms applied by
    UniProt
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to
    orthologs using Ensembl Compara
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: file:human/HMGCR/HMGCR-uniprot.txt
  title: UniProtKB entry P04035 (HMDH_HUMAN), 3-hydroxy-3-methylglutaryl-coenzyme A reductase
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Curated UniProt record for HMGCR; source of catalytic-activity, subcellular
      location and topology statements used as file: supporting text.
- id: PMID:10698924
  title: 'Crystal structure of the catalytic portion of human HMG-CoA reductase: insights
    into regulation of activity and catalysis.'
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Human catalytic-domain crystal structures with HMG-CoA, CoA and NADP(+); defines
      catalysis, cofactor/CoA binding and homotetramer/homodimer state. Supports
      GO:0004420, GO:0120225, GO:0070402.
- id: PMID:17180682
  title: Localization of the pre-squalene segment of the isoprenoid biosynthetic pathway
    in mammalian peroxisomes.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      Supports ER and peroxisomal localization of pre-squalene isoprenoid enzymes;
      peroxisomal claim is contested, so treated as non-core for HMGCR.
- id: PMID:18540668
  title: Thermodynamic and structure guided design of statin based inhibitors of 3-hydroxy-3-methylglutaryl
    coenzyme A reductase.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      Statin-inhibitor structure/design paper; treats HMGCR as the mevalonate-pathway
      target enzyme. Basis for the NAS isoprenoid-biosynthesis annotation.
- id: PMID:21357570
  title: Epigallocatechin-3-gallate potently inhibits the in vitro activity of hydroxy-3-methyl-glutaryl-CoA
    reductase.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Direct in vitro human HMGCR activity measurement (rate-controlling enzyme of
      cholesterol synthesis). Supports GO:0004420.
- id: PMID:23063590
  title: Artemisinic acid inhibits melanogenesis through downregulation of C/EBP α-dependent
    expression of HMG-CoA reductase gene.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      Links HMGCR-dependent cholesterol synthesis to melanogenesis via downregulation
      of HMGCR expression; basis of the cholesterol-biosynthetic-process IDA. The
      cholesterol-biosynthesis role itself is independently well established.
- id: PMID:23169578
  title: The UBIAD1 prenyltransferase links menaquinone-4 [corrected] synthesis to
    cholesterol metabolic enzymes.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      Reports a physical HMGCR-UBIAD1 interaction (Y2H + IP); basis of a protein binding
      IPI, flagged as over-annotated because the GO term is uninformative.
- id: PMID:2991281
  title: Human 3-hydroxy-3-methylglutaryl coenzyme A reductase. Conserved domains
    responsible for catalytic activity and sterol-regulated degradation.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Human full-length cDNA; defines catalytic C-terminal domain and sterol-regulated
      membrane domain / ER membrane topology. Supports GO:0004420 and ER membrane.
- id: PMID:33961781
  title: Dual proteome-scale networks reveal cell-specific remodeling of the human
    interactome.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      Proteome-scale AP-MS interactome (BioPlex); source of a generic protein binding
      IPI, flagged as over-annotated.
- id: PMID:36745799
  title: Limb girdle muscular disease caused by HMGCR mutation and statin myopathy
    treatable with mevalonolactone.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Experimental catalytic characterization of human HMGCR and an LGMDR28 variant,
      kinetics, statin inhibition, and disease context. Supports GO:0004420 and the
      rate-limiting cholesterol-synthesis role.
- id: PMID:6995544
  title: Multivalent feedback regulation of HMG CoA reductase, a control mechanism
    coordinating isoprenoid synthesis and cell growth.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Classic study of HMGCR as the mevalonate-synthesizing enzyme under multivalent
      feedback regulation. Supports GO:0004420 and pathway/regulatory context.
- id: Reactome:R-HSA-1655826
  title: Expression of 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase (HMGCR)
  findings: []
- id: Reactome:R-HSA-191352
  title: HMGCR dimer reduces bHMG-CoA to MVA
  findings: []
- id: Reactome:R-HSA-9621410
  title: HMGCR gene expression
  findings: []
- id: Reactome:R-HSA-9705584
  title: HMGCR dimer binds statins
  findings: []